Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/30/2008WO2008129276A1 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008129270A2 Compositions comprising anti-inflammatory compounds
10/30/2008WO2008129256A2 Hiv therapy
10/30/2008WO2008129255A1 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
10/30/2008WO2008129239A2 Use of agents that inhibit homologous recombination for the treatment of cancer
10/30/2008WO2008129191A2 Palatable product
10/30/2008WO2008129152A1 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008129094A1 Method for the chemical synthesis of capsinoids
10/30/2008WO2008129080A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
10/30/2008WO2008129077A2 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation
10/30/2008WO2008129075A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds
10/30/2008WO2008129071A1 Inhibitors of protein kinases
10/30/2008WO2008129070A1 Inhibitors of protein kinases
10/30/2008WO2008129069A1 Inhibitors of protein kinases
10/30/2008WO2008129066A1 Dermatological composition for the prevention and/or treatment of rosacea, of couperose or of skin which exhibits diffuse redness or small dilated vessels
10/30/2008WO2008129054A2 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008WO2008129043A1 Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
10/30/2008WO2008129029A1 Phthalazine and isoquinoline derivatives with slp receptor modulating activities
10/30/2008WO2008129023A2 Oligonucleotide compositions for the treatment of alzheimer's disease
10/30/2008WO2008129000A1 Pyridopyrimidine derivatives and use thereof in the treatment of itch and itch related disorders
10/30/2008WO2008128997A1 Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseases
10/30/2008WO2008128996A1 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128995A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128994A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128987A1 Novel inhibitors
10/30/2008WO2008128986A1 Urea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128984A1 Aminopyrimidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128983A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128982A1 Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128981A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128962A1 Tricyclic compounds as antibacterials
10/30/2008WO2008128961A1 Compounds
10/30/2008WO2008128960A1 Process for dosing self-emulsifying drug delivery systems
10/30/2008WO2008128953A1 Tricyclic nitrogen containing heterocycles as antibacterial agents
10/30/2008WO2008128951A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
10/30/2008WO2008128942A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008WO2008128919A2 Histamine h3 receptor ligands comprising a cyclobutoxy group
10/30/2008WO2008128892A1 Polyethylene glycol esters and cosmetic and/or dermatological preparations
10/30/2008WO2008128891A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008WO2008128889A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
10/30/2008WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
10/30/2008WO2008128792A1 Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
10/30/2008WO2008128791A2 Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen
10/30/2008WO2008128786A1 Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
10/30/2008WO2008128779A1 Ophthalmic oil-in-water emulsions containing prostaglandins
10/30/2008WO2008128765A1 Beverage composition comprising cla
10/30/2008WO2008128740A1 Titration of tapentadol
10/30/2008WO2008128739A1 Tapentadol for treating pain from arthritis
10/30/2008WO2008128704A1 Use of hydroxytyrosol as anti-aging agent
10/30/2008WO2008128703A1 Novel use of hydroxytyrosol and olive extracts/concentrates containing it
10/30/2008WO2008128685A1 Use of a composition comprising formoterol and beclometasone dipropionate for the prevention and/or treatment of an exacerbation of asthma
10/30/2008WO2008128654A2 Use of fungicides for treating fish mycoses
10/30/2008WO2008128653A1 Oxazolidinone for the treatment and prophylaxis of pulmonary hypertension
10/30/2008WO2008128647A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008WO2008128640A1 Use of fungicides for treating fish mycoses
10/30/2008WO2008128629A1 Novel use of hydroxytyrosol
10/30/2008WO2008128627A2 Topically applicable fungicide agents for treating nails
10/30/2008WO2008128552A1 Novel use of hydroxytyrosol and olive extracts/concentrates containing it
10/30/2008WO2008128538A1 Src family kinase inhibitors
10/30/2008WO2008128440A1 A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
10/30/2008WO2008128436A1 Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
10/30/2008WO2008128431A1 L-stepholidine (l-spd) derivatives, preparation method and usage thereof
10/30/2008WO2008128428A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008WO2008128366A1 Active ingredient combination for the prophylaxis of occlusive vascular diseases and cancer
10/30/2008WO2008128344A1 Small-molecule hepatitis c virus (hcv) ns3/4a serine protease inhibitors
10/30/2008WO2008128343A1 Boron-containing compounds, uses and preparation thereof
10/30/2008WO2008128335A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/30/2008WO2008128321A1 Therapeutic pro-antibiotic agents and methods of use thereof
10/30/2008WO2008128299A1 Therapeutic protocol for treating hemoglobinopathy
10/30/2008WO2008128280A1 Method and system for transdermal administration of volatile active
10/30/2008WO2008112166A3 Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
10/30/2008WO2008112159A3 Monocyclic anilide spirolactam cgrp receptor antagonists
10/30/2008WO2008109546A3 Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof
10/30/2008WO2008109516A3 Nucleic acid compounds for inhibiting ras gene expression and uses thereof
10/30/2008WO2008109427A3 Anesthetic spray composition
10/30/2008WO2008109381A3 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof
10/30/2008WO2008109380A3 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
10/30/2008WO2008109055A3 Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor
10/30/2008WO2008108793A3 Prevention of nuclear, solar, and other radiation-induced tissue damage
10/30/2008WO2008107771A3 2',3'-di-o-acyl-5-fluoronucleosides
10/30/2008WO2008107677A3 Thiadiazole and oxadiazole derivatives for the treatment of neurodegenerative disorders
10/30/2008WO2008106692B1 Pim kinase inhibitors and methods of their use
10/30/2008WO2008106166A3 Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors
10/30/2008WO2008106144A3 Implants for the treatment of psychiatric states
10/30/2008WO2008105822A3 Antimicrobial compositions
10/30/2008WO2008104812A3 C21-de0xy ansamycin derivatives as antitumor agents
10/30/2008WO2008103185A3 Substituted carboxamides as group i metabotropic receptor antagonists
10/30/2008WO2008101238A3 Natural products from vinca
10/30/2008WO2008100985A3 Combination of lbh589 with other therapeutic agents for treating cancer
10/30/2008WO2008100635A8 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
10/30/2008WO2008098995A9 Genes involved in mitochondrial biogenesis
10/30/2008WO2008097835A3 Compositions and methods for the treatment of metabolic disorders
10/30/2008WO2008097341A3 Antiviral compounds and use thereof
10/30/2008WO2008095841A3 Nitric oxide donor compounds
10/30/2008WO2008095027A3 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
10/30/2008WO2008094877A3 Compositions for oral delivery of pharmaceuticals
10/30/2008WO2008094687A3 Gep, a novel chondrogenic growth factor and target in cartilage disorders
10/30/2008WO2008089310A3 Delta 5 desaturase inhibitors for the treatment of obesity
1 ... 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 ... 7860